Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Non Cancer Pain × Oxycodone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 13 Neoplasms 13 Cancer Pain 13 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Neuralgia 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lymphoma 2 Inflammation 2 Bronchiolitis Obliterans Syndrome 2 Agnosia 2 Acute Pain 2 Waldenstrom Macroglobulinemia 1 Urinary Tract Infections 1 Trigger Finger Disorder 1 Thrombocythemia, Essential 1 Staphylococcal Infections 1 Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1 Spasm 1 Sleep Initiation and Maintenance Disorders 1 Sezary Syndrome 1 Sepsis 1 Seizures 1 Schizophrenia, Treatment-Resistant 1 Schizophrenia 1 Retinitis 1 Renal Insufficiency, Chronic 1 Pulmonary Arterial Hypertension 1 Primary Myelofibrosis 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01918098 2017-11-14

Targin for Non-cancer Pain

Mundipharma (China) Pharmaceutical Co. Ltd

Phase 3 Completed

Non Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡